Efficacy and Safety of a Probiotic Product in Children With Antibiotic-associated Gastrointestinal Disorders.
Phase 2
Completed
- Conditions
- Antibiotic-associated Loose/Watery Stools
- Registration Number
- NCT01940913
- Lead Sponsor
- Probi AB
- Brief Summary
To assess the tolerability and effect of a probiotic product, when co-administered with antibiotics, on the incidence and duration of loose/watery stools following the antibiotic treatment in children.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Reduction of the incidence of loose/watery stools following antibiotic treatment in children. 19-24 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Multicenter study at 13 health care centers in Warsaw
🇵🇱Warsaw, Poland
Multicenter study at 13 health care centers in Warsaw🇵🇱Warsaw, Poland